Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 18.05.2026 3 BMC Neurol 1 Brain 6 Diabet Med 1 Diabetes 11 Diabetes Res Clin Pract 1 J Autoimmun 1 J Immunol 3 J Neuroimmunol 2 J Neurol 1 J Pediatr Endocrinol Metab 1 Lancet 7 Lancet Neurol 3 Mult Scler 5 N Engl J Med 1 Neurol Clin Pract 3 Neurology 6 PLoS One 1 Proc Natl Acad Sci U S A 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. WANG Z, Tang J, Yang K, Cui Z, et al
   Diagnostic challenges and lessons learned of Guillain-Barre syndrome mimicking central nervous system infection - a case report.
   BMC Neurol. 2026 May 13. doi: 10.1186/s12883-026-04942.
   PubMed         Abstract available
   
   
2. ZHOU J, Wang T, Chen G, Yang S, et al
   Association between Guillain-Barre syndrome and 7 autoimmune diseases: a mendelian randomization study.
   BMC Neurol. 2026 May 9. doi: 10.1186/s12883-026-04957.
   PubMed         Abstract available
   
   
3. PENG JT, Kong XY, Li R, Cao YY, et al
   Efficacy and safety of low-dose trazodone hydrochloride for insomnia in patients with myasthenia gravis.
   BMC Neurol. 2026 May 8. doi: 10.1186/s12883-026-04962.
   PubMed         Abstract available
   
   

   
   Brain

4. GEORGIEVA ZG, Howlett SK, Rainbow DB, Coppard V, et al
   Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosis.
   Brain. 2026 May 13:awag171. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabet Med

5. ABDEL-MAGID M, Cockcroft EJ, Bright C, Mann RH, et al
   Policy gaps in type 1 diabetes: A UK audit of National Governing Bodies.
   Diabet Med. 2026 Feb 27:e70280. doi: 10.1111/dme.70280.
   PubMed         Abstract available
   
   
6. ROBERSON N, Holmes-Truscott E, Skinner TC, Halliday J, et al
   Shifting the narrative from 'what's wrong?' to 'what's strong?' MIND-MAP: A qualitative study exploring positive mental health and support needs of adults with diabetes.
   Diabet Med. 2026 Mar 12:e70273. doi: 10.1111/dme.70273.
   PubMed         Abstract available
   
   
7. ASAAD M, Ghazaleh HA, Tzouvara V, Aljohani N, et al
   'Darkness as we face the unknown': Biopsychosocial-spiritual experiences of parents of children and young people with type 1 diabetes from the Middle East and North Africa (MENA) region.
   Diabet Med. 2026 Mar 29:e70303. doi: 10.1111/dme.70303.
   PubMed         Abstract available
   
   
8. SKLAR J, Harel S, Lipska KJ, Lukasik J, et al
   When the system fails: Barriers to type 1 diabetes medication access and the emergent role of social media support.
   Diabet Med. 2026 Apr 17:e70313. doi: 10.1111/dme.70313.
   PubMed         Abstract available
   
   
9. D'SILVA N, Gillespie KM, Hendrieckx C, Wisting L, et al
   Evaluation of a novel eating disorder prevention programme (Australian diabetes body project) for young women with type 1 diabetes in a clinic setting: A randomized controlled trial protocol.
   Diabet Med. 2026 Apr 9:e70302. doi: 10.1111/dme.70302.
   PubMed         Abstract available
   
   
10. BOIKO O, Barnard-Kelly K, Vercauteren J, Greenfield SM, et al
    Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed-methods study.
    Diabet Med. 2026 Apr 3:e70297. doi: 10.1111/dme.70297.
    PubMed         Abstract available
    
    

    
    Diabetes

11. AMENDOLARA R, De Vita F, Abedi V, Luvera D, et al
    Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
    Diabetes. 2026 May 11:db250933. doi: 10.2337/db25-0933.
    PubMed         Abstract available
    
    

    
    Diabetes Res Clin Pract

12. HOFER G, Goode S, Renstrom F, Brandle M, et al
    Diabetes mellitus complications and their association with patient-reported outcome measures: a longitudinal study of the SwissDiab cohort.
    Diabetes Res Clin Pract. 2026;236:113263.
    PubMed         Abstract available
    
    
13. SOYER AK, Akarsu GC, Yelli BD, Tural Balsak BO, et al
    Evaluation of large language models for carbohydrate counting in type 1 diabetes mellitus: a comparative study with patient estimations.
    Diabetes Res Clin Pract. 2026;236:113279.
    PubMed         Abstract available
    
    
14. WANG CA, Wang WJ, Chen JY, Jiang ZH, et al
    Impact of sodium-glucose cotransporter-2 inhibitors on clinical outcomes in patients with type 1 diabetes after dialysis-requiring acute kidney injury: a real-world cohort study.
    Diabetes Res Clin Pract. 2026;236:113277.
    PubMed         Abstract available
    
    
15. KIM HY, Ji E, Kim J
    Temporal trends in macrovascular complications in young-onset diabetes in Korea: A nationwide population-based study.
    Diabetes Res Clin Pract. 2026;236:113285.
    PubMed         Abstract available
    
    
16. DELGADO N, Chaytor NS, Beeri MS, Hawks ZW, et al
    Plasma biomarkers of neurodegeneration and their associations with type 1 diabetes characteristics and glycemia.
    Diabetes Res Clin Pract. 2026;236:113256.
    PubMed         Abstract available
    
    
17. SEGET S, Rusak E, Pelicand J, Fry M, et al
    Automated insulin delivery use in children and adolescents with type 1 diabetes across the world.
    Diabetes Res Clin Pract. 2026;236:113253.
    PubMed         Abstract available
    
    
18. MIN H, Liu X, Zhao L, Yang X, et al
    Alterations in gray matter structure associated with cognitive decline in T1DM patients and mice: A voxel-based morphometry study.
    Diabetes Res Clin Pract. 2026;236:113252.
    PubMed         Abstract available
    
    
19. ODEH R, Murad H, Hani FB, Gharaibeh L, et al
    A prospective evaluation of attitudes, behaviors, and clinical outcomes among Jordanian children and adolescents with type 1 diabetes who fasted during Ramadan: a comparison of the 2021 and 2026 IDF-DAR risk scores.
    Diabetes Res Clin Pract. 2026;236:113242.
    PubMed         Abstract available
    
    
20. DAWSON C, Earnest A, Zomer E, Paul E, et al
    Comorbidities/cardiovascular risk factors and acute glycaemic emergencies in patients with type 1 and type 2 diabetes: The Australian National Diabetes Audit.
    Diabetes Res Clin Pract. 2026;236:113241.
    PubMed         Abstract available
    
    
21. FONTANAROSA A, Iommi M, Cesanelli F, Pompei A, et al
    Epidemiology of coeliac disease in children and adolescents with type 1 diabetes: a 13-year population-based study using secondary data sources.
    Diabetes Res Clin Pract. 2026;236:113238.
    PubMed         Abstract available
    
    
22. MCCARTHY A, Zaremba N, Thomas J, Pouwer F, et al
    Meeting time in range and time below range targets is not associated with psychological outcomes in type 1 or insulin-treated type 2 diabetes in the Hypo-METRICS study.
    Diabetes Res Clin Pract. 2026;236:113220.
    PubMed         Abstract available
    
    

    
    J Autoimmun

23. SAYADI A, Eloranta ML, Oparina N, Wallgren M, et al
    Single-cell RNA-seq reveals a persistent interferon signature in immune cells from systemic lupus erythematosus patients with high versus low polygenic risk scores despite antimalarial treatment.
    J Autoimmun. 2026;161:103575.
    PubMed         Abstract available
    
    

    
    J Immunol

24. GANUGULA R, Babalola KT, Arora M, Maruvada V, et al
    Combined cyclosporine A and urolithin A therapy ameliorates murine lupus nephritis.
    J Immunol. 2026;215:vkag087.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

25. MESSINA C
    Transient global amnesia or a broader autoimmune Spectrum? Reassessing a paraneoplastic case.
    J Neuroimmunol. 2026;418:578964.
    PubMed        
    
    
26. SUN B, Zou L, Li J, Yang H, et al
    Sequential efgartigimod-rituximab therapy in autoimmune nodopathy: A feasibility report on shortening the washout interval for B-cell depletion.
    J Neuroimmunol. 2026;418:578963.
    PubMed         Abstract available
    
    
27. BAE Y, Jang M, Bak KY, Park JH, et al
    Association between irritable bowel syndrome and Guillain-Barre syndrome-related immune-mediated peripheral neuropathies: A nationwide cohort study.
    J Neuroimmunol. 2026;418:578961.
    PubMed         Abstract available
    
    

    
    J Neurol

28. FILIPPI M, D'Amico E, Brescia Morra V, Zanetta C, et al
    Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.
    J Neurol. 2026;273:302.
    PubMed         Abstract available
    
    
29. ANDERSEN RK, Ankjaer P, Axelsen KH, Andersen LK, et al
    Prevalence and characteristics of patients with seronegative myasthenia gravis.
    J Neurol. 2026;273:308.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

30. KARA E, Aycan Z
    Serum selenium levels in children and adolescents with Hashimoto's thyroiditis: a cross-sectional case-control study.
    J Pediatr Endocrinol Metab. 2026 May 12. doi: 10.1515/jpem-2025-0677.
    PubMed         Abstract available
    
    

    
    Lancet

31. MORAND EF, Dall'Era M, Sanchez-Guerrero J, Pearson DR, et al
    Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.
    Lancet. 2026;407:1809-1824.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

32. TOOSY A, Oertel FC, Petzold A, Albrecht P, et al
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:539-540.
    PubMed        
    
    
33. OKUDA DT, Kantarci OH, Siva A, Pelletier D, et al
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:539.
    PubMed        
    
    
34. KRIEGER S
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:540-541.
    PubMed        
    
    
35. MONTALBAN X, Oh J, Coetzee T, Thompson AJ, et al
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' reply.
    Lancet Neurol. 2026;25:542-543.
    PubMed        
    
    
36. ZETTL UK, Rommer PS, Wattjes MP, Tumani H, et al
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:542.
    PubMed        
    
    
37. SONODA Y, Hagiwara A, Tomizawa Y, Hatano T, et al
    Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:544.
    PubMed        
    
    
38. SATI P, Barkhof F, Reich DS, Ontaneda D, et al
    Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' reply.
    Lancet Neurol. 2026;25:545.
    PubMed        
    
    

    
    Mult Scler

39. KIM KH, Kang YR, Kim SH, Hyun JW, et al
    Rarity of silent progression: PIRA and RAW in myelin oligodendrocyte glycoprotein antibody-associated disease.
    Mult Scler. 2026;32:642-646.
    PubMed         Abstract available
    
    
40. PALLADINO R, Marrie RA, Affinito G, Majeed A, et al
    Recalibration and external validation of vascular risk calculators for multiple sclerosis: A population-based study using CPRD data in England, 1987-2023.
    Mult Scler. 2026 May 12:13524585261444243. doi: 10.1177/13524585261444243.
    PubMed         Abstract available
    
    
41. AMIN M, Nakamura K, Thoomukuntla B, Carlson AK, et al
    Paramagnetic rim lesions on 7T MRI after autologous hematopoietic cell transplantation.
    Mult Scler. 2026;32:647-651.
    PubMed         Abstract available
    
    

    
    N Engl J Med

42. LAFAYETTE R, Brenner RM, Barratt J
    Targeting CD20 versus APRIL or BAFF and APRIL for IgA Nephropathy. Reply.
    N Engl J Med. 2026;394:1962-1963.
    PubMed        
    
    
43. KA SM, Chen A, Wu CC
    Targeting CD20 versus APRIL or BAFF and APRIL for IgA Nephropathy.
    N Engl J Med. 2026;394:1962.
    PubMed        
    
    
44. LV J, Liu L, Wang W, Wang X, et al
    Telitacicept for IgA Nephropathy - Interim Analysis of a Phase 3 Trial.
    N Engl J Med. 2026;394:1916-1924.
    PubMed         Abstract available
    
    
45. ALLENBACH Y, Benveniste O
    Inflammatory Myopathies.
    N Engl J Med. 2026;394:1925-1938.
    PubMed         Abstract available
    
    
46. LUNDBERG IE
    A Phase 3 Trial of Brepocitinib in Dermatomyositis.
    N Engl J Med. 2026;394:1953-1955.
    PubMed        
    
    

    
    Neurol Clin Pract

47. SIGNORI A, Montobbio N, Bovis F, Ponzano M, et al
    Uncoupling Relapse Reduction and Disability Progression: Evidence From Tolebrutinib Studies.
    Neurol Clin Pract. 2026;16:e200612.
    PubMed         Abstract available
    
    

    
    Neurology

48. O'CONNOR L, Gabrysch K, Wikstrom AK, Rostedt Punga A, et al
    Risk of Myasthenia Gravis Exacerbation During Pregnancy and Postpartum: A Nationwide Cohort Study.
    Neurology. 2026;106:e218082.
    PubMed         Abstract available
    
    
49. KIM W, Watt CL, Fung SG, Yoo S, et al
    Multiple Sclerosis and Outpatient Physician Care in the Last Years of Life: A Population-Based Study.
    Neurology. 2026;106:e218067.
    PubMed         Abstract available
    
    
50. LANZANTE M, Cerase A, de Mauro A, Forti A, et al
    Bridging the Gap: Balo Concentric Sclerosis-Like Leukoencephalopathy in Chronic Cocaine Use: A 1-Year Clinical and Imaging Follow-Up of 2 Cases.
    Neurology. 2026;106:e218068.
    PubMed         Abstract available
    
    

    
    PLoS One

51. SINAN NA, Almujaydil MS
    Cafestol ameliorates diabetic nephropathy via Keap1-Nrf2 axis activation: A novel renoprotective mechanism independent of glycemic control.
    PLoS One. 2026;21:e0349192.
    PubMed         Abstract available
    
    
52. SU S, Lin Y
    Identification of a diagnostic metabolomic fingerprint in plasma for eosinophilic granulomatosis with polyangiitis.
    PLoS One. 2026;21:e0343182.
    PubMed         Abstract available
    
    
53. DASTANI M, Sajjadi MS, Yamout B, Arab Bafrani M, et al
    Evaluation of the performance of large language models in responding to medical questions related to multiple sclerosis: A case study of large language models including ChatGPT, Gemini, Grok and Copilot.
    PLoS One. 2026;21:e0346445.
    PubMed         Abstract available
    
    
54. SINGHAL P, Srivastava P, Rajasekhar L
    Psychological well-being of SLE patients: A comprehensive examination of stress, depression, anxiety and quality of life.
    PLoS One. 2026;21:e0344330.
    PubMed         Abstract available
    
    
55. LUO Y, Gao H, Wang M, Wang Z, et al
    The ketogenic diet alleviates autoimmune thyroiditis caused by Th17/Treg imbalance by inhibiting the HMGB1/NLRP3 signaling pathway.
    PLoS One. 2026;21:e0341564.
    PubMed         Abstract available
    
    
56. NAKAJIMA T, Kitagori K, Funakoshi S, Shirakashi M, et al
    Significance of RGS13 expression in lupus B cells.
    PLoS One. 2026;21:e0348945.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

57. FAISSNER S, Gold R
    Beyond antibodies in GAD65 autoimmunity: Reframing pathogenesis through intrathecal B-T cell cross-talk.
    Proc Natl Acad Sci U S A. 2026;123:e2609144123.
    PubMed        
    
    

    
    Thyroid

58. SASAKI T, Kihara M, Fujishima M, Masuoka H, et al
    Markedly Elevated Preoperative Thyroid-Stimulating Hormone Levels and Greater Operative Difficulty in Graves' Disease: A Single-Center Cohort Study.
    Thyroid. 2026 May 13:10507256261449452. doi: 10.1177/10507256261449452.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum